1700029I01Rik Activators
1700029I01Rik Activators are a class of chemicals distinguished by their ability to specifically increase the expression of the 1700029I01Rik gene, a distinct genetic sequence in mice coding for a particular protein or RNA molecule with a defined role in cellular physiology. The interaction of a compound with the gene's promoter results in an amplified production of the reporter, with the ensuing luminescence serving as a measurable indicator of gene activation. Compounds that produce a significant increase in luminescence are marked as potential activators and earmarked for further analysis. Quantitative PCR (qPCR) is a critical tool used at this stage to measure the mRNA levels of the 1700029I01Rik gene in the presence of these chemical agents. This precise quantification allows for the confirmation that the substances indeed enhance gene transcription. Western blot analysis provides a synergistic approach to verify that the increase in mRNA is accompanied by a corresponding increase in the gene's protein product.
This technique can also reveal whether the activator compounds affect the stability or post-translational processing of the protein, thereby offering a more nuanced understanding of the activators' impact on gene expression. By integrating the quantitative data from qPCR with the qualitative insights gained from Western blotting, a robust profile of each activator's influence on 1700029I01Rik gene expression is constructed. These assays can discern if the activators interact directly with the DNA sequences that regulate 1700029I01Rik, or if they modify the chromatin structure to promote the binding of transcription factors necessary for initiating gene transcription. Additionally, immunofluorescence microscopy can be employed to assess any changes in the subcellular localization of the 1700029I01Rik protein that the activators may induce. Such changes can provide clues to alterations in the protein's function or interactions within the cell.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a known inhibitor of various protein kinases. By inhibiting competitive signaling pathways, EGCG may indirectly promote pathways that upregulate or activate the functional activity of 1700029I01Rik. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium concentrations. This elevation can activate calcium-dependent proteins and signaling cascades that may interact with or enhance 1700029I01Rik activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a PKC activator which mimics diacylglycerol. Activation of PKC can lead to phosphorylation of downstream proteins that may work synergistically with 1700029I01Rik to enhance its activity. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
S1P operates through G-protein coupled receptors to activate intracellular signaling cascades. These pathways can include cross-talk with proteins such as 1700029I01Rik, potentially enhancing its activity. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 transports calcium across cell membranes, affecting intracellular signaling. Elevated calcium signaling can activate proteins and pathways that may interact with 1700029I01Rik, leading to its enhanced activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that alters the PI3K/AKT pathway. Modulating this pathway can affect the activity of downstream proteins, potentially leading to enhanced activity of 1700029I01Rik. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 selectively inhibits p38 MAPK. Through inhibiting p38 MAPK, SB203580 may shift signaling to alternative pathways that could involve and activate 1700029I01Rik. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor that may reduce competitive signaling, potentially allowing signaling pathways that interact with 1700029I01Rik to be more active and enhance its functional activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is an inhibitor of PI3K, modifying the PI3K/AKT pathway. This alteration may redirect signaling to pathways that involve 1700029I01Rik, indirectly enhancing its activity. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a broad-spectrum protein kinase inhibitor. Although its effects are wide-ranging, it may lead to the selective activation of pathways related to 1700029I01Rik by inhibiting kinases that otherwise suppress it. | ||||||